Literature DB >> 29391337

Intracranial Bleeding in a Female Hemophilia Patient: Molecular Analysis of the Factor 8 Gene and Determination of a Novel Mutation

Burçak Tatlı Güneş1, Zühal Önder Siviş1, Eda Ataseven1, Barış Malbora1, Meral Türker1, Fatma Burcu Belen2, Berna Atabay1, Tahir Atik3, Esra Işık3, Ferda Özkınay3.   

Abstract

Entities:  

Keywords:  Hemophilia; Intracranial bleeding; Female

Mesh:

Substances:

Year:  2018        PMID: 29391337      PMCID: PMC6110442          DOI: 10.4274/tjh.2017.0385

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN: 1300-7777            Impact factor:   1.831


× No keyword cloud information.

To the Editor,

An 11-month-old female patient was admitted to the emergency department with right occipital fracture and epidural hematoma. The father had severe hemophilia A and the parents were cousins. Laboratory tests revealed normal complete blood count and prolonged activated partial thromboplastin time. Mixing test results were normalized after mixing with normal plasma. After plasma samples were collected for further diagnostic tests, fresh frozen plasma and dexamethasone were administered. The factor VIII level was 0.1%, 35%, and 0.5% for the patient, mother, and father, respectively. The patient’s von Willebrand factor (VWF) level was 128 IU/mL, VWF:Ricof was 110 IU/mL, collagen ADP was 110 (reference: 71-118) s, and collagen epinephrine was 98 (reference: 85-165) s. Intron 22 inversion was investigated with the IS-PCR method and was found to be normal. Whole-genome analysis including all exonic regions of the F8 gene (NM_000132.3) was conducted and the homozygous c.608T>C (L203P) mutation was found. This mutation was not previously reported. As this variant was not reported in any exome databases (ExAC, EVS) and as it was shown to be the cause of the disease in at least three in silico protein modeling programs, the mutation was considered as a novel mutation causing hemophilia A (“probably damaging” with 0.987 PolyPhen2 score, “disease causing” with 0.999 MutationTaster score, and “damaging” with 0 SIFT score). The mutation was also confirmed by Sanger sequencing (Figure 1). Plasma-derived FVIII at 2x500 IU/day was administered for 14 days followed by 300 IU/week prophylaxis. Inhibitor screening at the 5th and 10th exposure days was negative.
Figure 1

Sanger sequencing confirmation: (a) the mother (b), the father, and (c) the patient show heterozygous, hemizygous, and homozygous c.608T>C (L203P) mutation in the F8 gene.

Hemophilia A is rarely seen in female patients due to skewed inactivation of the X chromosome leading to inactivation of the wild-type X chromosome, anomalies like Turner syndrome, or translocations, as well as homozygous/compound heterozygous mutations for hemophilia A [1,2,3,4,5]. The karyotype analysis of our patient revealed 46,XX. The patient and the father were hemizygous and mother was heterozygous for the c.608T>C (L203P) mutation (Figure 2). The clinical situation of our patient as she was admitted with epidural hematoma requiring surgical intervention and the fact that the family did not apply for prenatal diagnosis before birth point out the importance of prenatal diagnosis in regions where consanguineous marriage is common.
Figure 2

Family tree. The patient was homozygous, the father hemizygous, and mother heterozygous for the c.608T>C (L203P) mutation.

  5 in total

1.  Inversion of intron 22 of the factor VIII gene in a girl with severe hemophilia A and Turner's syndrome.

Authors:  A Chuansumrit; W Sasanakul; A Goodeve; T Treratvirapong; R Parinayok; P Pintadit; P Hathirat
Journal:  Thromb Haemost       Date:  1999-10       Impact factor: 5.249

2.  Female haemophilia A caused by skewed X inactivation.

Authors:  K E Knobe; E Sjörin; M J Soller; H Liljebjörn; R C R Ljung
Journal:  Haemophilia       Date:  2008-05-29       Impact factor: 4.287

3.  Female haemophiliac homozygous for the factor VIII intron 22 inversion mutation, with transcriptional inactivation of one of the factor VIII alleles.

Authors:  D David; S Morais; C Ventura; M Campos
Journal:  Haemophilia       Date:  2003-01       Impact factor: 4.287

4.  Molecular mechanisms underlying hemophilia A phenotype in seven females.

Authors:  A Pavlova; H Brondke; J Müsebeck; H Pollmann; A Srivastava; J Oldenburg
Journal:  J Thromb Haemost       Date:  2009-03-19       Impact factor: 5.824

5.  Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females.

Authors:  Nisa K Renault; Sarah Dyack; Melanie J Dobson; Teresa Costa; Wan L Lam; Wenda L Greer
Journal:  Eur J Hum Genet       Date:  2007-03-07       Impact factor: 4.246

  5 in total
  2 in total

Review 1.  Genetic causes of haemophilia in women and girls.

Authors:  Connie H Miller; Christopher J Bean
Journal:  Haemophilia       Date:  2020-12-13       Impact factor: 4.263

2.  Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations

Authors:  Tahir Atik; Esra Işık; Hüseyin Onay; Bilçağ Akgün; Moharram Shamsali; Kaan Kavaklı; Melike Evim; Gülen Tüysüz; Namık Yaşar Özbek; Fahri Şahin; Zafer Salcıoğlu; Canan Albayrak; Yeşim Oymak; Ekrem Ünal; Fatma Burcu Belen; Ebru Yılmaz Keskin; Can Balkan; Birol Baytan; Alphan Küpesiz; Vildan Culha; Tuba Nur Tahtakesen Güçer; Adalet Meral Güneş; Ferda Özkınay
Journal:  Turk J Haematol       Date:  2020-02-06       Impact factor: 1.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.